IN HEPG2 CELLS, TRANSLOCATION, NOT DEGRADATION, DETERMINES THE FATE OF THE DE-NOVO SYNTHESIZED APOLIPOPROTEIN-B

被引:62
作者
BONNARDEL, JA [1 ]
DAVIS, RA [1 ]
机构
[1] SAN DIEGO STATE UNIV,DEPT BIOL,MAMMALIAN CELL & MOLEC BIOL LAB,SAN DIEGO,CA 92182
关键词
D O I
10.1074/jbc.270.48.28892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies show that translocation and degradation of apolipoprotein B (apoB), two processes occurring on or within the endoplasmic reticulum, determine how much de novo synthesized apoB is secreted. We determined which of these processes regulates the intracellular fate of apoB by examining whether degradation determines how much apoB is translocated or if translocation determines how much apoB is degraded. HepG2 cells, treated with the cysteine active site protease inhibitor ALLN, previously shown to block the degradation of translocation-arrested apoB in Chinese hamster ovary cells (Du, E., Kurth, J., Wang, S.-L., Humiston, P., and Davis, R. A. (1994) J. Biol. Chem. 269, 24169-24176), showed a 10-fold increase in the accumulation of de novo synthesized [S-35] methionine-labeled apoB. The majority (80%) of the apoB accumulated in response to ALLN was in the microsomal fraction, In contrast, ALLN did not effect apoB secretion, Since ALLN did not effect the intracellular accumulation of [S-35]methionine-labeled albumin and other proteins (trichloroacetic acid precipitable [S-35]methionine-labeled proteins), its effect on apoB was specific. Pulse-chase studies showed that ALLN dramatically reduced the first-order rate of removal of [S-35]methionine-labeled apoB from the cell but did not effect its rate of secretion. The finding that ALLN caused the intracellular accumulation of incompletely translated chains of apoB suggests that at least some of the degradation occurs at the ribosomal level. Moreover, 85% of the apoB that accumulated in isolated microsomes in response to ALLN was accessible to exogenous trypsin, indicating this pool of apoB was incompletely translocated. The combined data suggest that translocation, not degradation, determines the intracellular fate of de novo synthesized apoB.
引用
收藏
页码:28892 / 28896
页数:5
相关论文
共 50 条
[41]   Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells [J].
Wu, XJ ;
Shang, AM ;
Jiang, HS ;
Ginsberg, HN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3347-3355
[42]   Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cells [J].
Bourdon, Emmanuel ;
Loreau, Nadine ;
Lagrost, Laurent ;
Davignon, Jean ;
Bernier, Lise ;
Blache, Denis .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (05) :786-796
[43]   The soy phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion by HepG2 cells [J].
Wilcox, LJ ;
de Dreu, LE ;
Borradaile, NM ;
Huff, MW .
CIRCULATION, 1999, 100 (18) :109-110
[44]   REGULATION OF APOLIPOPROTEIN AI AND APO-B EXPRESSION IN HEPG2 CELLS BY BUTYRATE [J].
HAGHPASSAND, M ;
BAMBERGER, MJ ;
MOBERLY, JB .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 :A140-A140
[45]   Atherogenic effects of oxidised LDL on apolipoprotein AI and B synthesis in HEPG2 cells [J].
Bourdon, E ;
Loreau, N ;
Davignon, J ;
Bernier, L ;
Blache, D .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 :S140-S140
[46]   THE HUMAN HEPATOBLASTOMA HEPG2 CELL IS HETEROZYGOUS FOR A 3 AMINO-ACID DELETION IN THE SIGNAL PEPTIDE OF APOLIPOPROTEIN-B [J].
GORDON, DA ;
THANASSI, JA .
FASEB JOURNAL, 1992, 6 (01) :A371-A371
[47]   EXPRESSION OF APOLIPOPROTEIN-B INVITRO IN CELL-FREE LYSATES OF HEPG2 CELLS - EVIDENCE THAT INSULIN MODULATES APO-B SYNTHESIS AT THE TRANSLATIONAL LEVEL [J].
THERIAULT, A ;
CHEUNG, R ;
ADELI, K .
CLINICAL BIOCHEMISTRY, 1992, 25 (05) :321-323
[48]   Inhibition of the microsomal triglyceride transfer protein decreases apolipoprotein B secretion without affecting its translocation in HepG2 cells. [J].
Macri, J ;
Kulinski, A ;
Thibert, RJ ;
Adeli, K .
CLINICAL CHEMISTRY, 1998, 44 :A79-A79
[49]   STUDIES OF THE SITES OF INTRACELLULAR DEGRADATION OF APOLIPOPROTEIN-B IN HEP G2 CELLS [J].
FURUKAWA, S ;
SAKATA, N ;
GINSBERG, HN ;
DIXON, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (31) :22630-22638
[50]   BUTYRATE STIMULATES THE SECRETION OF APOLIPOPROTEIN B-100-CONTAINING LIPOPROTEINS FROM HEPG2 CELLS BY INHIBITING THE INTRACELLULAR DEGRADATION [J].
KAPTEIN, A ;
DEWIT, ECM ;
PRINCEN, HMG .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1213 (03) :349-356